End-of-day quote
Shenzhen S.E.
18:00:00 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
21.08
CNY
|
+1.05%
|
|
+4.36%
|
-8.98%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,206
|
19,830
|
22,959
|
18,782
|
13,803
|
12,564
|
-
|
-
|
Enterprise Value (EV)
1 |
12,230
|
18,266
|
21,903
|
16,608
|
11,574
|
10,167
|
10,168
|
10,041
|
P/E ratio
|
21.9
x
|
24.2
x
|
24.7
x
|
18.6
x
|
25.2
x
|
13.3
x
|
9.92
x
|
10.1
x
|
Yield
|
1.29%
|
0.9%
|
0.78%
|
1.27%
|
1.73%
|
2.27%
|
2.32%
|
2.81%
|
Capitalization / Revenue
|
1.26
x
|
1.57
x
|
1.57
x
|
1.08
x
|
0.79
x
|
0.63
x
|
0.53
x
|
0.49
x
|
EV / Revenue
|
1.17
x
|
1.44
x
|
1.5
x
|
0.95
x
|
0.67
x
|
0.51
x
|
0.43
x
|
0.39
x
|
EV / EBITDA
|
12.4
x
|
15.8
x
|
16.9
x
|
11
x
|
10.6
x
|
5.65
x
|
4.84
x
|
4.58
x
|
EV / FCF
|
15.7
x
|
-
|
-
|
-
|
-
|
5.61
x
|
4.6
x
|
4.27
x
|
FCF Yield
|
6.36%
|
-
|
-
|
-
|
-
|
17.8%
|
21.7%
|
23.4%
|
Price to Book
|
2.95
x
|
3.44
x
|
3.49
x
|
2.53
x
|
1.78
x
|
1.49
x
|
1.26
x
|
1.21
x
|
Nbr of stocks (in thousands)
|
567,770
|
595,313
|
596,181
|
596,071
|
596,005
|
596,005
|
-
|
-
|
Reference price
2 |
23.26
|
33.31
|
38.51
|
31.51
|
23.16
|
21.08
|
21.08
|
21.08
|
Announcement Date
|
20-02-27
|
21-02-07
|
22-03-14
|
23-03-17
|
24-03-19
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,479
|
12,656
|
14,587
|
17,432
|
17,380
|
20,071
|
23,767
|
25,466
|
EBITDA
1 |
986.1
|
1,157
|
1,295
|
1,511
|
1,087
|
1,799
|
2,102
|
2,191
|
EBIT
1 |
739.2
|
917.9
|
1,068
|
1,243
|
786.4
|
1,362
|
1,620
|
1,692
|
Operating Margin
|
7.05%
|
7.25%
|
7.32%
|
7.13%
|
4.52%
|
6.78%
|
6.82%
|
6.64%
|
Earnings before Tax (EBT)
1 |
749.1
|
956.9
|
1,097
|
1,235
|
702.6
|
1,208
|
1,589
|
1,581
|
Net income
1 |
603.9
|
790
|
921.6
|
1,010
|
549.4
|
967.7
|
1,295
|
1,267
|
Net margin
|
5.76%
|
6.24%
|
6.32%
|
5.79%
|
3.16%
|
4.82%
|
5.45%
|
4.97%
|
EPS
2 |
1.063
|
1.378
|
1.556
|
1.697
|
0.9206
|
1.587
|
2.124
|
2.082
|
Free Cash Flow
1 |
777.4
|
-
|
-
|
-
|
-
|
1,812
|
2,210
|
2,350
|
FCF margin
|
7.42%
|
-
|
-
|
-
|
-
|
9.03%
|
9.3%
|
9.23%
|
FCF Conversion (EBITDA)
|
78.84%
|
-
|
-
|
-
|
-
|
100.75%
|
105.12%
|
107.27%
|
FCF Conversion (Net income)
|
128.73%
|
-
|
-
|
-
|
-
|
187.24%
|
170.67%
|
185.54%
|
Dividend per Share
2 |
0.3000
|
0.3000
|
0.3000
|
0.4000
|
0.4000
|
0.4775
|
0.4900
|
0.5922
|
Announcement Date
|
20-02-27
|
21-02-07
|
22-03-14
|
23-03-17
|
24-03-19
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,089
|
3,995
|
3,970
|
4,060
|
5,406
|
4,436
|
4,240
|
4,137
|
4,567
|
5,100
|
4,807
|
4,781
|
5,232
|
5,336
|
5,642
|
EBITDA
1 |
126.7
|
225.6
|
396.1
|
433.6
|
-
|
-
|
-
|
-
|
-
|
-
|
365.9
|
365.9
|
374.2
|
406.6
|
421
|
EBIT
1 |
210.2
|
202.4
|
252.5
|
291.4
|
496.3
|
279.1
|
291.6
|
215.8
|
-
|
285.2
|
322.2
|
300.5
|
276.3
|
331.7
|
344.3
|
Operating Margin
|
5.14%
|
5.07%
|
6.36%
|
7.18%
|
9.18%
|
6.29%
|
6.88%
|
5.22%
|
-
|
5.59%
|
6.7%
|
6.29%
|
5.28%
|
6.22%
|
6.1%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
241.9
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4.74%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.2700
|
0.3035
|
0.4000
|
0.4400
|
0.5600
|
0.4017
|
0.4500
|
0.3000
|
-
|
0.4059
|
0.4109
|
0.3476
|
0.3925
|
0.4141
|
0.4345
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.4000
|
-
|
-
|
-
|
0.4575
|
Announcement Date
|
22-03-14
|
22-04-29
|
22-08-18
|
22-10-27
|
23-03-17
|
23-04-20
|
23-08-19
|
23-10-30
|
24-03-19
|
24-04-26
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
977
|
1,564
|
1,056
|
2,174
|
2,229
|
2,397
|
2,395
|
2,523
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
777
|
-
|
-
|
-
|
-
|
1,812
|
2,210
|
2,350
|
ROE (net income / shareholders' equity)
|
14%
|
15.8%
|
15%
|
14.5%
|
6.97%
|
12.4%
|
13.2%
|
12.8%
|
ROA (Net income/ Total Assets)
|
7.89%
|
9.14%
|
7.79%
|
-
|
-
|
6.7%
|
6.3%
|
7%
|
Assets
1 |
7,659
|
8,643
|
11,833
|
-
|
-
|
14,444
|
20,554
|
18,094
|
Book Value Per Share
2 |
7.900
|
9.690
|
11.00
|
12.50
|
13.00
|
14.20
|
16.80
|
17.40
|
Cash Flow per Share
2 |
1.730
|
1.740
|
3.030
|
4.190
|
3.550
|
3.450
|
3.310
|
3.950
|
Capex
1 |
205
|
277
|
387
|
345
|
230
|
1,827
|
722
|
977
|
Capex / Sales
|
1.96%
|
2.19%
|
2.65%
|
1.98%
|
1.32%
|
9.1%
|
3.04%
|
3.84%
|
Announcement Date
|
20-02-27
|
21-02-07
|
22-03-14
|
23-03-17
|
24-03-19
|
-
|
-
|
-
|
Last Close Price
21.08
CNY Average target price
24.16
CNY Spread / Average Target +14.60% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.98% | 1.74B | | -33.59% | 14.96B | | -23.15% | 11.07B | | +9.74% | 6.13B | | -10.91% | 5.98B | | +0.88% | 4.76B | | +53.60% | 4.36B | | -10.49% | 3.73B | | -12.53% | 3.43B | | -7.34% | 3.02B |
Other Drug Retailers
|